IDEAYA Biosciences (NASDAQ: IDYA)
IDEAYA Biosciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
IDEAYA Biosciences Company Info
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
News & Analysis
Why Ideaya Biosciences Stock Is Plummeting Today
Ideaya stock is getting hit hard following a recent press release from the company.
3 Healthcare Stocks That Surged Last Week
Here's what pushed up shares of the highest-flying healthcare stocks.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.